Judgment of the General Court (Eighth Chamber) of 2 March 2022
Debregeas et associés Pharma (D & A Pharma) v European Commission and European Medicines Agency
Medicinal products for human use – Application for conditional marketing authorisation for the medicinal product Hopveus – sodium oxybate – Decision of refusal by the Commission – Regulation (EC) No 726/2004 – Procedure – Committee for Medicinal Products for Human Use – Request for consultation of a specific scientific advisory group – Impartiality of members of an ad hoc committee of experts – Manifest errors of assessment – Equal treatment
Case T-556/20
Reports of Cases
published in the electronic Reports of Cases (Court Reports - general - 'Information on unpublished decisions' section)
Links to the texts
|
Curia |
EUR-Lex |
Autres Liens |
Judgment
ECLI:EU:T:2022:111 |
|
|
|